Menu Search
Equities

Shanghai MicroPort EP Medtech Co Ltd

688351:SHH

Shanghai MicroPort EP Medtech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)20.37
  • Today's Change-0.540 / -2.58%
  • Shares traded2.02m
  • 1 Year change-8.20%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shanghai MicroPort EP Medtech Co Ltd grew revenues 26.46% from 260.32m to 329.19m while net income improved 85.17% from 3.07m to 5.69m.
Gross margin57.86%
Net profit margin9.35%
Operating margin9.92%
Return on assets1.95%
Return on equity2.10%
Return on investment2.05%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Shanghai MicroPort EP Medtech Co Ltd fell by 322.59m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 37.97m for operations while cash used for investing totalled 274.66m.
Cash flow per share--
Price/Cash flow per share--
Book value per share3.68
Tangible book value per share3.45
More ▼

Balance sheet in CNYView more

Shanghai MicroPort EP Medtech Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio15.07
Quick ratio13.82
Total debt/total equity0.011
Total debt/total capital0.0109
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.